Xeris Biopharma Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 10.82 M | $36.68 M | 0.81% | 7.26% |
| VANGUARD GROUP INC | 02/11/2025 | 7.90 M | $26.78 M | 1.72% | 5.30% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.35 M | $11.36 M | 0.54% | 2.25% |
| ROSALIND ADVISORS, INC. | 02/14/2025 | 3.10 M | $10.53 M | 0.00% | 2.08% |
| AIGH CAPITAL MANAGEMENT LLC | 02/12/2025 | 2.57 M | $8.73 M | 17.81% | 1.73% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 2.10 M | $7.12 M | 31.28% | 1.41% |
| CAXTON CORP | 02/14/2025 | 2.02 M | $6.83 M | -60.59% | 1.35% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.95 M | $6.61 M | 34.78% | 1.31% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 1.90 M | $6.45 M | 13.63% | 1.28% |
| UBS GROUP AG | 02/14/2025 | 1.73 M | $5.88 M | 512.35% | 1.16% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.59 M | $5.39 M | 90.16% | 1.07% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 1.36 M | $4.62 M | 38.42% | 0.92% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.04 M | $3.54 M | 166.21% | 0.70% |
| KNOTT DAVID M JR | 02/12/2025 | 1.00 M | $3.39 M | 0.00% | 0.67% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 834,940 | $2.83 M | -21.83% | 0.56% |
| CENTERBOOK PARTNERS LP | 02/13/2025 | 690,077 | $2.34 M | -80.18% | 0.46% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 666,095 | $2.26 M | 10.12% | 0.45% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 594,015 | $2.01 M | 100.00% | 0.40% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 578,511 | $1.96 M | 464.99% | 0.39% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 02/07/2025 | 474,955 | $1.61 M | 100.00% | 0.32% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 465,112 | $1.58 M | -1.38% | 0.31% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 459,608 | $1.56 M | 90.26% | 0.31% |
| REDMILE GROUP, LLC | 02/14/2025 | 451,099 | $1.53 M | -56.90% | 0.30% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 402,872 | $1.37 M | -0.12% | 0.27% |
| BARCLAYS PLC | 02/13/2025 | 347,642 | $1.18 M | 7.14% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 322,375 | $1.09 M | -2.09% | 0.22% |
| JANE STREET GROUP, LLC | 02/14/2025 | 306,245 | $1.04 M | -3.93% | 0.21% |
| TUDOR INVESTMENT CORP ET AL | 02/14/2025 | 305,186 | $1.03 M | -39.85% | 0.20% |
| IHT WEALTH MANAGEMENT, LLC | 02/14/2025 | 270,160 | $915,856 | -2.43% | 0.18% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 230,467 | $781,283 | 9.31% | 0.15% |
| EAM INVESTORS, LLC | 02/13/2025 | 222,377 | $753,858 | 100.00% | 0.15% |
| LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 216,693 | $734,000 | -42.73% | 0.15% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 209,923 | $711,640 | -3.30% | 0.14% |
| BROWN ADVISORY INC | 02/14/2025 | 190,255 | $644,964 | 0.00% | 0.13% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 187,443 | $635,000 | 0.00% | 0.13% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 182,317 | $618,055 | 100.00% | 0.12% |
| RHUMBLINE ADVISERS | 01/30/2025 | 180,964 | $613,459 | 4.27% | 0.12% |
| DIVERSIFIED TRUST CO | 01/07/2025 | 175,739 | $595,755 | 0.00% | 0.12% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 171,332 | $580,815 | 106.16% | 0.12% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 170,482 | $578,000 | 5.91% | 0.11% |
| ALPINE GLOBAL MANAGEMENT, LLC | 02/18/2025 | 160,000 | $542,400 | 0.00% | 0.11% |
| THOMPSON SIEGEL & WALMSLEY LLC | 02/10/2025 | 152,784 | $518,000 | -11.58% | 0.10% |
| LEGATO CAPITAL MANAGEMENT LLC | 01/29/2025 | 142,164 | $481,936 | 100.00% | 0.10% |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | 02/14/2025 | 139,687 | $472,142 | -18.28% | 0.09% |
| CITIGROUP INC | 02/12/2025 | 132,446 | $448,991 | 10.90% | 0.09% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 131,570 | $446,022 | -10.93% | 0.09% |
| MACKENZIE FINANCIAL CORP | 02/20/2025 | 129,952 | $440,537 | 446.04% | 0.09% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 127,600 | $432,564 | 60.44% | 0.09% |
| GLOBEFLEX CAPITAL L P | 02/10/2025 | 125,210 | $424,462 | 100.00% | 0.08% |
| ROUNDVIEW CAPITAL LLC | 02/12/2025 | 120,000 | $406,800 | 100.00% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xeris Biopharma Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 170 institutional investors and hedge funds held shares of Xeris Biopharma Holdings, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 10.82 M
VANGUARD GROUP INC: 7.9 M
GEODE CAPITAL MANAGEMENT, LLC: 3.35 M
Rosalind Advisors, Inc.: 3.1 M
AIGH Capital Management LLC: 2.57 M
RENAISSANCE TECHNOLOGIES LLC: 2.1 M
43.96% of Xeris Biopharma Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 72.16 M shares in the last 24 months. This purchase volume represents approximately $255.46 M in transactions.